Skip to main content
Livermore
Livermore
ZHEN

Avoro Capital Advisors LLC

SEC CIK
0001633313
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Avoro Capital Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Avoro Capital Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−12,222,222−100.0%Sold outHolders
Q1 202612,222,222$491.7M4.8%00.0%UnchangedHolders
Q4 202512,222,222$307.0M3.0%00.0%UnchangedHolders
Q3 202512,222,222$276.6M3.6%00.0%UnchangedHolders
Q2 202512,222,222$211.6M3.7%00.0%UnchangedHolders
Q1 202512,222,222$267.3M4.2%00.0%UnchangedHolders
Q4 202412,222,222$390.0M5.5%+1,111,111+10.0%AddedHolders
Q3 202411,111,111$320.4M4.7%00.0%UnchangedHolders
Q2 202411,111,111$426.2M5.7%00.0%UnchangedHolders
Q1 202411,111,111$653.1M7.6%00.0%UnchangedHolders
Q4 202311,111,111$665.1M9.2%00.0%UnchangedHolders
Q3 202311,111,111$422.7M6.6%00.0%UnchangedHolders
Q2 202311,111,111$1.01B13.7%00.0%UnchangedHolders
Q1 202311,111,111$732.9M10.9%+486,111+4.6%AddedHolders
Q4 202210,625,000$549.4M8.2%+500,000+4.9%AddedHolders
Q3 202210,125,000$691.5M12.8%+320,000+3.3%AddedHolders
Q2 20229,805,000$443.4M8.8%+355,000+3.8%AddedHolders
Q1 20229,450,000$480.2M8.8%+894,445+10.5%AddedHolders
Q4 20218,555,555$404.5M6.9%+3,555,555+71.1%AddedHolders
Q3 20215,000,000$164.8M2.6%+3,994,770+397.4%AddedHolders
Q2 20211,005,230$63.5M1.1%+5,230+0.5%AddedHolders
Q1 20211,000,000$42.9M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.